EP081/#1043 Cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery: a case series from mirebalais, Haiti. (4th December 2022)
- Record Type:
- Journal Article
- Title:
- EP081/#1043 Cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery: a case series from mirebalais, Haiti. (4th December 2022)
- Main Title:
- EP081/#1043 Cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery: a case series from mirebalais, Haiti
- Authors:
- Millien, Christophe
Henderson, Rebecca
Hubert, Jean Joel Saint
Ulysse, Jean-Claude
Triedman, Scott
Fadelu, Temidayo
Slater, Sarah
Mckenzie, Nathalie
Mutombo, Alex
Lormil, Joarly
Randall, Tom - Abstract:
- Abstract : Objectives: In Haiti, a low-resource setting where radiotherapy is unavailable, significant numbers of women present with locally advanced cervical cancer in need of treatment. We built a multidisciplinary team to collaboratively implement neoadjuvant chemotherapy followed by surgery, and aimed to retrospectively assess the efficacy and feasibility of this approach. Methods: We implemented paclitaxel/carboplatin neoadjuvant chemotherapy (NACT) followed by radical surgery for women with stage IB2-IIA cervical cancer at the Hospital Universitaire de Mirebalais (HUM). Three Haitian gynecologists worked remotely with expert clinicians to pilot the program. We aimed to determine the feasibility and safety of this approach in this resource limited setting. Results: Between January of 2021 and May of 2022, 26 of 310 women diagnosed with cervical cancer at HUM received NACT followed by radical surgery. Women in the pilot sample were ages 38 to 69 years. Twenty-three received six cycles of chemotherapy, while the remainder received three cycles. As of May 2022, 16 had undergone radical surgery, three were lost to follow-up during chemotherapy, two were inoperable, and five were receiving chemotherapy. Of women undergoing radical surgery, two were found to have metastatic disease during surgery and one was found to have a recurrence of disease. There were no perioperative deaths. One woman experienced sepsis and developed a vesicovaginal fistula. Conclusions: PreliminaryAbstract : Objectives: In Haiti, a low-resource setting where radiotherapy is unavailable, significant numbers of women present with locally advanced cervical cancer in need of treatment. We built a multidisciplinary team to collaboratively implement neoadjuvant chemotherapy followed by surgery, and aimed to retrospectively assess the efficacy and feasibility of this approach. Methods: We implemented paclitaxel/carboplatin neoadjuvant chemotherapy (NACT) followed by radical surgery for women with stage IB2-IIA cervical cancer at the Hospital Universitaire de Mirebalais (HUM). Three Haitian gynecologists worked remotely with expert clinicians to pilot the program. We aimed to determine the feasibility and safety of this approach in this resource limited setting. Results: Between January of 2021 and May of 2022, 26 of 310 women diagnosed with cervical cancer at HUM received NACT followed by radical surgery. Women in the pilot sample were ages 38 to 69 years. Twenty-three received six cycles of chemotherapy, while the remainder received three cycles. As of May 2022, 16 had undergone radical surgery, three were lost to follow-up during chemotherapy, two were inoperable, and five were receiving chemotherapy. Of women undergoing radical surgery, two were found to have metastatic disease during surgery and one was found to have a recurrence of disease. There were no perioperative deaths. One woman experienced sepsis and developed a vesicovaginal fistula. Conclusions: Preliminary results suggest that NACT followed by radical surgery is feasible and safe in a resource limited setting, and may improve the chance for cure for women who otherwise might be offered comfort measures only. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 32(2022)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 32(2022)Supplement 3
- Issue Display:
- Volume 32, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 3
- Issue Sort Value:
- 2022-0032-0003-0000
- Page Start:
- A81
- Page End:
- A81
- Publication Date:
- 2022-12-04
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2022-igcs.172 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24965.xml